Alzheimer, Dementia & Memory Health • ICD-10-CM F01.50
Dementia - multi-infarction
Audited by the DotMD AI Specialist Council
•
FDA DailyMed SPL: 2026-11-02 • ICD-10-CM F01.50 • 8 Linked .gov / PubMed Citations
•
Governance: Dr. Hannah Lindqvist, MD, PhD (NPI #1457952647)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary
Dementia - multi-infarction Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Dementia - multi-infarction—coded clinically as F01.50 across Memory & Cognition guidelines—combines reversible metabolic/medication/sleep-apnea workup [Dementia - multi-infarction F01.50] with structured follow-up of MoCA Cognitive Screening in Dementia - multi-infarction (F01.50: Score) (>= 26 / 30 (F01.50)).
- 2 Real-world patient consensus: Diagnostic registry F01.50: Dementia - multi-infarction is managed within Memory & Cognition.
- 3 Typical cash cost range: Clinicians assessing Dementia - multi-infarction focus on neuroinflammatory microglial activation [Dementia - multi-infarction F01.50] and targeted history.
- 4 Top reported side effects / signs: Longitudinal Dementia - multi-infarction monitoring tracks TSH & Fasting in Dementia - multi-infarction (F01.50: ApoB / HbA1c) toward Optimal cardiometabolic neuroprotection (F01.50).
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data
3 of 3 Free Questions RemainingAsk our AI Specialists anything about Dementia - multi-infarction
What Is Dementia - multi-infarction?
Dementia - multi-infarction—coded clinically as F01.50 across Memory & Cognition guidelines—combines reversible metabolic/medication/sleep-apnea workup [Dementia - multi-infarction F01.50] with structured follow-up of MoCA Cognitive Screening in Dementia - multi-infarction (F01.50: Score) (>= 26 / 30 (F01.50)).
Pathophysiology, Underlying Causes & Clinical Presentation
In Dementia - multi-infarction (F01.50), physiological disruption stems from neuroinflammatory microglial activation [Dementia - multi-infarction F01.50], informing Alzheimer, Dementia & Memory Health protocols that track MoCA Cognitive Screening in Dementia - multi-infarction (F01.50: Score) (>= 26 / 30 (F01.50)).
Common Symptoms & Clinical Signs
- • Presentation of Dementia - multi-infarction (F01.50): word-finding pauses, difficulty in Dementia - multi-infarction (F01.50: managing multi-step finances,)
- • Secondary Dementia - multi-infarction clinical sign: subtle personality shifts, in Dementia - multi-infarction (F01.50: apathy, or evening)
- • Symptom flares in Dementia - multi-infarction correlating with TSH & Fasting in Dementia - multi-infarction (F01.50: ApoB / HbA1c) deviation outside Optimal cardiometabolic neuroprotection (F01.50)
- • Functional memory & cognition impact requiring reversible metabolic/medication/sleep-apnea workup [Dementia - multi-infarction F01.50] evaluation (F01.50)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Dementia - multi-infarction Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F01.50 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Alzheimer, Dementia & Memory Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: TSH & Fasting in Dementia - multi-infarction (F01.50: ApoB / HbA1c) | Optimal cardiometabolic neuroprotection (F01.50) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: MoCA Cognitive Screening in Dementia - multi-infarction (F01.50: Score) | >= 26 / 30 (F01.50) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Homocysteine & Vitamin in Dementia - multi-infarction (F01.50: B12) | Homocysteine < 9 umol/L; B12 > 500 pg/mL (F01.50) | Clinical Reference Target Range |
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance
Check Drug Interactions →
FDA-Monographed Medications & Public Cash Price Reference for Dementia - multi-infarction
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Healmusz Multi-Purposetreatment (Tolnaftate 1% Multi-Purposetreatment) Healmusz Multi-Purposetreatment • RxCUI 313423-B85248058 | Over-the-Counter Clinical Monograph | 87% | $0.0883 | $ 14.85 /mo |
| Mucinex Childrens Multi-Symptom Cold and Flu (Acetaminophen, Dextromethorphan Hbr) Mucinex Childrens Multi-Symptom Cold and Flu • RxCUI 1919076-B72854070 | Sigma-1 Agonist | 90% | $0.0194 | $ 9.90 /mo |
| Visine Allergy Eye Relief Multi-Action (Naphazoline Hydrochloride and Pheniramine Maleate) Visine Allergy Eye Relief Multi-Action • RxCUI 1043658 | Over-the-Counter Clinical Monograph | 78% | $0.5569 | $ 48.60 /mo |
| Dimetapp Multi-Symptom Cold and Flu (Acetaminophen, Diphenhydramine Hydrochloride) Dimetapp Multi-Symptom Cold and Flu • RxCUI 2683420 | Histamine-1 Receptor Antagonist | 77% | $0.0439 | $ 11.66 /mo |
| Triderma Intense Fast Healing Multi-Purpose Cream (Calendula Officinalis) Triderma Intense Fast Healing Multi-Purpose Cream • RxCUI RXN-B10738060 | Over-the-Counter Clinical Monograph | 90% | $2.0700 | $ 157.54 /mo |
| Night Time Cold and Flu Relief Multi Symptom (Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate) Night Time Cold and Flu Relief Multi Symptom • RxCUI 1094549 | Antihistamine | 90% | $0.0194 | $ 9.90 /mo |
| Minovia Mini Minovia Mini Generic • RxCUI RXN-85477924-2008 | Vitamin A | 83% | $3.2900 | $ 141.75 /mo |
| Theraflu Multi-Symptom Severe Cold (Acetaminophen, Dextromethorphan Hbr, Phenylephrine HCl) Theraflu Multi-Symptom Severe Cold • RxCUI 1189316 | Sigma-1 Agonist | 81% | $0.0194 | $ 9.90 /mo |
| Serynth Multi-Purpose Funcus (Tolnaftate 1% Multi-Purpose Funcus) Serynth Multi-Purpose Funcus • RxCUI 313421-B85248133 | Over-the-Counter Clinical Monograph | 74% | $0.0883 | $ 14.85 /mo |
| Xbofpen Multi-Purpose Treatment (Tolnaftate 1% Multi-Purpose Treatment) Xbofpen Multi-Purpose Treatment • RxCUI 313423-B87786038 | Over-the-Counter Clinical Monograph | 93% | $0.0883 | $ 14.85 /mo |
| Tussin Multi Symptom Cold Cf (Dextromethorphan Hbr, Guaifenesin, Phenylephrine Hci) Tussin Multi Symptom Cold Cf • RxCUI 1044949-B700000133 | Expectorant | 75% | $0.0195 | $ 9.91 /mo |
| Cold Childrens, Multi Symptom (Dextromethorphan Hbr, Guaifenesin, Phenylephrine HCl) Cold Childrens, Multi Symptom • RxCUI 1043543-B69842570 | Expectorant | 78% | $0.1020 | $ 15.84 /mo |
| Original Night-Time Multi-Symptom Cold/Flu Relief (Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate) Original Night-Time Multi-Symptom Cold/Flu Relief • RxCUI 1043400 | Antihistamine | 94% | $0.0194 | $ 9.90 /mo |
| Allergy Multi-Symptom (Acetaminophen, Chlorpheniramine Maleate and Phenylephrine HCl) Allergy Multi-Symptom • RxCUI 1046781 | Histamine-1 Receptor Antagonist | 80% | $0.0828 | $ 14.46 /mo |
| Amazon Childrens Multi Symptom Cold (Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride) Amazon Childrens Multi Symptom Cold • RxCUI 1043543-B72288649 | Expectorant | 90% | $0.0975 | $ 15.52 /mo |
| Discount Drug Mart Eye Drops Multi-Symptom Relief (Polyethylene Glycol 400, Tetrahydrozoline HCl, Zinc Sulfate) Discount Drug Mart Eye Drops Multi-Symptom Relief • RxCUI 2360903 | Copper Absorption Inhibitor | 81% | $0.0185 | $ 9.83 /mo |
Dr. Lin (AI PubMed Clinical Trial Lead)
Browse All PubMed Translations →
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Dementia - multi-infarction)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and: What a 545-Participant Study Found If the primary end points are met, the data will provide confirmatory evidence of the clinical and biomarker benefits of hydromethylthionine mesylate in minimal to moderate AD. The journal of prevention of Alzheimer's disease • 2022-01-15 • Phase III Randomized Trial | N = 545 | 93/100 | PMID 36281683 ↗ |
| Can This Approach Help? Inside the Latest Research on Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's At Week 10, the differences of brexpiprazole 1 and 2 mg versus placebo for NPI total score were -1.2 (p = 0.5891) and -8.4 (p < 0.0001), and those for NPI-Distress total score were -1.1 (p = 0.2292) and -3.9 (p < 0.0001),... Alzheimer's & dementia : the journal of the Alzheimer's Association • 2025-07-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40717666 ↗ |
| Can This Approach Help? Inside the Latest Research on Brexpiprazole With Antidepressants for Agitation in Alzheimer's Dementia: Post In this exploratory post hoc analysis, brexpiprazole improved agitation symptoms and was generally well tolerated in participants with Alzheimer's dementia with and without concomitant antidepressants. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry • 2026-11-15 • Phase III Randomized Trial | N = 97 | 88/100 | PMID 42502037 ↗ |
| Can This Approach Help? Inside the Latest Research on Cognitive and psychiatric side effects during adjunctive cenobamate treatment in Cognitive and psychiatric TEAEs were reported by similar numbers of cenobamate- and placebo-treated patients during gold-standard blind adjunctive cenobamate treatment (< 4 % of patients), and exposure-adjusted incidence rates... Epilepsy & behavior : E&B • 2024-02-15 • Phase III Randomized Trial | N = 108 | 88/100 | PMID 38184949 ↗ |
| Can This Approach Help? Inside the Latest Research on Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate The measurements used for the assessment of apathy in patients with AD had a high degree of overlap with the DCA. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry • 2021-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 32565008 ↗ |
Zero-PHI Patient Support & Cohort Discussions
Dementia - multi-infarction Patient Community & “People Like Me” Threads
“People Like Me” Cohort Filter (Zero-PHI)
Filter Dementia - multi-infarction community threads and patient logs by age, biological sex, dosage, and treatment duration.
No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Dementia - multi-infarction.